Skip to content
lifestyle.celebhomes.net
Home
Sample Page
Author:
LB Pharmaceuticals Inc
LB Pharmaceuticals Initiates Pivotal Phase 3 Trial (NOVA-2) for LB-102 in Patients with Schizophrenia
March 25, 2026
LB Pharmaceuticals Announces $100.0 Million Private Placement
February 5, 2026
←
Previous Page
1
2